Irene B Helenowski
Overview
Explore the profile of Irene B Helenowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1523
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abaza Y, Winer E, Guru Murthy G, Shallis R, Matthews A, Badar T, et al.
Am J Hematol
. 2024 Feb;
99(4):606-614.
PMID: 38342997
Venetoclax (VEN) combined with hypomethylating agents (HMAs) is the standard of care for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) unfit for intensive chemotherapy. To date,...
2.
Miller Y, Ghosh M, Merrick D, Kubala B, Szabo E, Bengtson L, et al.
Front Oncol
. 2023 Sep;
13:1204726.
PMID: 37711198
Introduction: Iloprost, a prostacyclin analog, has lung cancerpreventive activity in preclinical models and improved dysplasia in former smokers in a phase IIb trial. Oral iloprost is currently unavailable. We performed...
3.
Flum A, Oberlin D, Bachrach L, Jovanovic B, Helenowski I, Flury S, et al.
Urol Pract
. 2023 Aug;
2(6):367-372.
PMID: 37559311
Introduction: The surgical volume and training of the surgeon performing radical cystectomy can have a significant impact on bladder cancer outcomes. We hypothesize significant variability in the training and volume...
4.
Xu A, Panken E, Gonzales-Alabastro C, Zhang H, Helenowski I, Murphy A, et al.
Urology
. 2023 Jul;
179:78-79.
PMID: 37455201
No abstract available.
5.
Mahalingam D, Chen S, Xie P, Loghmani H, Heineman T, Kalyan A, et al.
Br J Cancer
. 2023 Jul;
129(5):782-790.
PMID: 37443348
Background: We previously reported activity of pelareorep, pembrolizumab and chemotherapy. Patients developed new T-cell clones and increased peripheral T-cell clonality, leading to an inflamed tumour. To evaluate a chemotherapy-free regimen,...
6.
Gentzler R, Mohindra N, Jalal S, Reckamp K, Hall R, Hanna N, et al.
Oncologist
. 2023 Jun;
29(1):47-56.
PMID: 37390616
Background: Combination chemotherapy and immunotherapy regimens have significantly improved survival for patients with previously untreated advanced non-small cell lung cancer (NSCLC). Improvements in overall survival (OS) in two separate pembrolizumab...
7.
Xu A, Panken E, Gonzales-Alabastro C, Zhang H, Helenowski I, Murphy A, et al.
Urology
. 2023 Jun;
179:71-79.
PMID: 37286139
Objective: To assess urologists' attitudes toward treating lesbian, gay, bisexual, transgender, or queer (LGBT) patients and counseling practices during diagnosis and treatment of prostate cancer. Methods: A 35-question survey was...
8.
Sonabend A, Gould A, Amidei C, Ward R, Schmidt K, Zhang D, et al.
Lancet Oncol
. 2023 May;
24(5):509-522.
PMID: 37142373
Background: Low-intensity pulsed ultrasound with concomitant administration of intravenous microbubbles (LIPU-MB) can be used to open the blood-brain barrier. We aimed to assess the safety and pharmacokinetics of LIPU-MB to...
9.
Schumacher F, Helenowski I, Sun Z, Oswald L, Gonzalez B, Moses K, et al.
Prostate Cancer Prostatic Dis
. 2023 Jan;
26(1):201-206.
PMID: 36709235
Background: Shared decision-making (SDM) for metastatic prostate cancer (mPC) engages patients in the decision-making process and may be associated with better outcomes relative to physician- or patient-directed decision-making. We assessed...
10.
Ho J, Chao C, Helenowski I, Dwyer A, Vavra A, Eskandari M, et al.
J Vasc Surg Venous Lymphat Disord
. 2022 Aug;
11(1):10-18.e1.
PMID: 35931361
Objective: Sonographers performing venous duplex ultrasound (VDUS) of patients with coronavirus disease 2019 (COVID-19) have an increased risk of exposure owing to their close contact with these patients for an...